Clostridium Difficile Vaccine 2-Dose Versus 3-Dose Study

PHASE3CompletedINTERVENTIONAL
Enrollment

1,994

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

December 22, 2020

Study Completion Date

December 22, 2020

Conditions
Clostridium Difficile Associated Disease
Interventions
BIOLOGICAL

Clostridium difficile

Toxoid-based Clostridium difficile vaccine

BIOLOGICAL

Placebo

Normal saline solution (0.9% sodium chloride)

Trial Locations (52)

14609

Rochester Clinical Research, Inc, Rochester

23114

Virginia Research Center LLC, Midlothian

27103

PMG Research of Winston-Salem, LLC, Winston-Salem

27408

PharmQuest, Greensboro

27609

PMG Research of Raleigh, Raleigh

28209

PMG Research of Charlotte LLC, Charlotte

28401

PMG Research of Wilmington, LLC, Wilmington

28601

Accellacare - Hickory, Hickory

29405

Coastal Carolina Research Center, North Charleston

29445

Medical Research South, Goose Creek

29566

Main Street Physician's Care - Waterway, Little River

31406

Meridian Clinical Research, LLC, Savannah

32127

Progressive Medical Research, Port Orange

32720

Accel Research Sites - DeLand Clinical Research Unit, DeLand

32801

Clinical Neuroscience Solutions, Inc., Orlando

32806

Clinical Neuroscience Solutions, Inc., Orlando

33026

Pines Care Research Center, LLC, Pembroke Pines

33142

Acevedo Clinical Research Associates, Miami

33756

Innovative Research of West Florida, Inc., Clearwater

35611

North Alabama Research Center, LLC, Athens

35801

Medical Affiliated Research Center, Huntsville

37620

Holston Medical Group, Bristol

39503

MedPharmics, LLC, Gulfport

43213

Aventiv Research Inc., Columbus

45419

PriMed Clinical Research, Dayton

46544

MOC Research, Mishawaka

58104

Lillestol Research LLC, Fargo

63005

Clinical Research Professionals Inc., Chesterfield

70006

MedPharmics, LLC, Metairie

76104

Texas Health Care, PLLC, Fort Worth

Ventavia Research Group, LLC, Fort Worth

77081

Texas Center for Drug Development, Inc., Houston

77375

DM Clinical Research, Tomball

Martin Diagnostic Clinic, Tomball

77401

Bellaire Doctor's Clinic, Bellaire

78229

Diagnostics Research Group, San Antonio

78726

ARC Clinical Research at Wilson Parke, Austin

80033

Paradigm Research, Wheat Ridge

83404

Snake River Research, PLLC, Idaho Falls

84020

J. Lewis Research Inc. / Foothill Family Clinic Draper, Draper

84095

J. Lewis Research, Inc. / Jordan River Family Medicine, South Jordan

84109

J. Lewis Research, Inc. / Foothill Family Clinic, Salt Lake City

84121

J. Lewis Research, Inc. / Foothill Family Clinic South, Salt Lake City

85018

HOPE Research Institute, Phoenix

The Pain Center of Arizona, Phoenix

85032

The Pain Center of Arizona, Phoenix

85224

East Valley Gastroenterology and Hepatology Associates, Chandler

85381

The Pain Center of Arizona, Peoria

91942

Paradigm Clinical Research Centers, Inc., La Mesa

96001

Paradigm Clinical Research Centers, Inc., Redding

98801

Wenatchee Valley Hospital & Clinics, Wenatchee

08869

Amici Clinical Research, Raritan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03918629 - Clostridium Difficile Vaccine 2-Dose Versus 3-Dose Study | Biotech Hunter | Biotech Hunter